9 results on '"Michele C. Walsh"'
Search Results
2. Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants
- Author
-
Haresh, Kirpalani, Edward F, Bell, Susan R, Hintz, Sylvia, Tan, Barbara, Schmidt, Aasma S, Chaudhary, Karen J, Johnson, Margaret M, Crawford, Jamie E, Newman, Betty R, Vohr, Waldemar A, Carlo, Carl T, D'Angio, Kathleen A, Kennedy, Robin K, Ohls, Brenda B, Poindexter, Kurt, Schibler, Robin K, Whyte, John A, Widness, John A F, Zupancic, Myra H, Wyckoff, William E, Truog, Michele C, Walsh, Valerie Y, Chock, Abbot R, Laptook, Gregory M, Sokol, Bradley A, Yoder, Ravi M, Patel, C Michael, Cotten, Melissa F, Carmen, Uday, Devaskar, Sanjay, Chawla, Ruth, Seabrook, Rosemary D, Higgins, Abhik, Das, and Marian, Willinger
- Subjects
Pediatrics ,medicine.medical_specialty ,Anemia ,Vision Disorders ,MEDLINE ,Infant, Premature, Diseases ,030204 cardiovascular system & hematology ,law.invention ,Hemoglobins ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,medicine ,Humans ,030212 general & internal medicine ,Hearing Loss ,Survival rate ,Obstetrics ,Extramural ,business.industry ,Cerebral Palsy ,Cognitive delay ,Infant, Newborn ,General Medicine ,medicine.disease ,Survival Rate ,Multicenter study ,Infant, Extremely Low Birth Weight ,Neurodevelopmental Disorders ,Infant, Extremely Premature ,Hemoglobin ,Cognition Disorders ,Erythrocyte Transfusion ,business ,Algorithms ,Infant, Premature - Abstract
Limited data suggest that higher hemoglobin thresholds for red-cell transfusions may reduce the risk of cognitive delay among extremely-low-birth-weight infants with anemia.We performed an open, multicenter trial in which infants with a birth weight of 1000 g or less and a gestational age between 22 weeks 0 days and 28 weeks 6 days were randomly assigned within 48 hours after delivery to receive red-cell transfusions at higher or lower hemoglobin thresholds until 36 weeks of postmenstrual age or discharge, whichever occurred first. The primary outcome was a composite of death or neurodevelopmental impairment (cognitive delay, cerebral palsy, or hearing or vision loss) at 22 to 26 months of age, corrected for prematurity.A total of 1824 infants (mean birth weight, 756 g; mean gestational age, 25.9 weeks) underwent randomization. There was a between-group difference of 1.9 g per deciliter (19 g per liter) in the pretransfusion mean hemoglobin levels throughout the treatment period. Primary outcome data were available for 1692 infants (92.8%). Of 845 infants in the higher-threshold group, 423 (50.1%) died or survived with neurodevelopmental impairment, as compared with 422 of 847 infants (49.8%) in the lower-threshold group (relative risk adjusted for birth-weight stratum and center, 1.00; 95% confidence interval [CI], 0.92 to 1.10; P = 0.93). At 2 years, the higher- and lower-threshold groups had similar incidences of death (16.2% and 15.0%, respectively) and neurodevelopmental impairment (39.6% and 40.3%, respectively). At discharge from the hospital, the incidences of survival without severe complications were 28.5% and 30.9%, respectively. Serious adverse events occurred in 22.7% and 21.7%, respectively.In extremely-low-birth-weight infants, a higher hemoglobin threshold for red-cell transfusion did not improve survival without neurodevelopmental impairment at 22 to 26 months of age, corrected for prematurity. (Funded by the National Heart, Lung, and Blood Institute and others; TOP ClinicalTrials.gov number, NCT01702805.).
- Published
- 2020
3. Causes and Timing of Death in Extremely Premature Infants from 2000 through 2011
- Author
-
Ravi M, Patel, Sarah, Kandefer, Michele C, Walsh, Edward F, Bell, Waldemar A, Carlo, Abbot R, Laptook, Pablo J, Sánchez, Seetha, Shankaran, Krisa P, Van Meurs, M Bethany, Ball, Ellen C, Hale, Nancy S, Newman, Abhik, Das, Rosemary D, Higgins, Barbara J, Stoll, and Janet, Taft
- Subjects
Pediatrics ,medicine.medical_specialty ,Gestational Age ,Infant, Premature, Diseases ,Article ,Congenital Abnormalities ,Enterocolitis, Necrotizing ,Risk Factors ,Cause of Death ,Infant Mortality ,medicine ,Humans ,Infant, Very Low Birth Weight ,Cause of death ,Respiratory distress ,business.industry ,Infant, Newborn ,Infant ,Gestational age ,General Medicine ,medicine.disease ,United States ,Confidence interval ,Infant mortality ,Bronchopulmonary dysplasia ,Infant, Extremely Premature ,Necrotizing enterocolitis ,Gestation ,business - Abstract
Understanding the causes and timing of death in extremely premature infants may guide research efforts and inform the counseling of families.We analyzed prospectively collected data on 6075 deaths among 22,248 live births, with gestational ages of 22 0/7 to 28 6/7 weeks, among infants born in study hospitals within the National Institute of Child Health and Human Development Neonatal Research Network. We compared overall and cause-specific in-hospital mortality across three periods from 2000 through 2011, with adjustment for baseline differences.The number of deaths per 1000 live births was 275 (95% confidence interval [CI], 264 to 285) from 2000 through 2003 and 285 (95% CI, 275 to 295) from 2004 through 2007; the number decreased to 258 (95% CI, 248 to 268) in the 2008-2011 period (P=0.003 for the comparison across three periods). There were fewer pulmonary-related deaths attributed to the respiratory distress syndrome and bronchopulmonary dysplasia in 2008-2011 than in 2000-2003 and 2004-2007 (68 [95% CI, 63 to 74] vs. 83 [95% CI, 77 to 90] and 84 [95% CI, 78 to 90] per 1000 live births, respectively; P=0.002). Similarly, in 2008-2011, as compared with 2000-2003, there were decreases in deaths attributed to immaturity (P=0.05) and deaths complicated by infection (P=0.04) or central nervous system injury (P0.001); however, there were increases in deaths attributed to necrotizing enterocolitis (30 [95% CI, 27 to 34] vs. 23 [95% CI, 20 to 27], P=0.03). Overall, 40.4% of deaths occurred within 12 hours after birth, and 17.3% occurred after 28 days.We found that from 2000 through 2011, overall mortality declined among extremely premature infants. Deaths related to pulmonary causes, immaturity, infection, and central nervous system injury decreased, while necrotizing enterocolitis-related deaths increased. (Funded by the National Institutes of Health.).
- Published
- 2015
4. Aggressive vs. Conservative Phototherapy for Infants with Extremely Low Birth Weight
- Author
-
Rosemary D. Higgins, Waldemar A. Carlo, Cathy Grisby, Abbot R. Laptook, Seetha Shankaran, Claudia Pedroza, Brenda H. Morris, Walid A. Salhab, Ronnie Guillet, William Oh, Brenda B. Poindexter, Maynard Rasmussen, Qing Yao, Avroy A. Fanaroff, Dale L. Phelps, W. Kenneth Poole, Rebecca Perritt, David K. Stevenson, Edward F. Donovan, Betty R. Vohr, Krisa P. Van Meurs, C. Michael Cotten, Georgia E. McDavid, Barbara J. Stoll, Shahnaz Duara, Abhik Das, Richard A. Ehrenkranz, Jon E. Tyson, T. Michael O'Shea, and Michele C. Walsh
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Bilirubin ,Developmental Disabilities ,Birth weight ,Article ,law.invention ,chemistry.chemical_compound ,Primary outcome ,Randomized controlled trial ,law ,Infant Mortality ,Birth Weight ,Humans ,Medicine ,business.industry ,Infant, Newborn ,Bayes Theorem ,Liter ,General Medicine ,Phototherapy ,Confidence interval ,Low birth weight ,Treatment Outcome ,chemistry ,Infant, Extremely Low Birth Weight ,Relative risk ,Female ,Hyperbilirubinemia, Neonatal ,medicine.symptom ,business - Abstract
It is unclear whether aggressive phototherapy to prevent neurotoxic effects of bilirubin benefits or harms infants with extremely low birth weight (1000 g or less).We randomly assigned 1974 infants with extremely low birth weight at 12 to 36 hours of age to undergo either aggressive or conservative phototherapy. The primary outcome was a composite of death or neurodevelopmental impairment determined for 91% of the infants by investigators who were unaware of the treatment assignments.Aggressive phototherapy, as compared with conservative phototherapy, significantly reduced the mean peak serum bilirubin level (7.0 vs. 9.8 mg per deciliter [120 vs. 168 micromol per liter], P0.01) but not the rate of the primary outcome (52% vs. 55%; relative risk, 0.94; 95% confidence interval [CI], 0.87 to 1.02; P=0.15). Aggressive phototherapy did reduce rates of neurodevelopmental impairment (26%, vs. 30% for conservative phototherapy; relative risk, 0.86; 95% CI, 0.74 to 0.99). Rates of death in the aggressive-phototherapy and conservative-phototherapy groups were 24% and 23%, respectively (relative risk, 1.05; 95% CI, 0.90 to 1.22). In preplanned subgroup analyses, the rates of death were 13% with aggressive phototherapy and 14% with conservative phototherapy for infants with a birth weight of 751 to 1000 g and 39% and 34%, respectively (relative risk, 1.13; 95% CI, 0.96 to 1.34), for infants with a birth weight of 501 to 750 g.Aggressive phototherapy did not significantly reduce the rate of death or neurodevelopmental impairment. The rate of neurodevelopmental impairment alone was significantly reduced with aggressive phototherapy. This reduction may be offset by an increase in mortality among infants weighing 501 to 750 g at birth. (ClinicalTrials.gov number, NCT00114543.)
- Published
- 2008
5. Inhaled Nitric Oxide in Preterm Infants Undergoing Mechanical Ventilation
- Author
-
Dan L. Stewart, David J. Durand, Richard J. Martin, Avital Cnaan, Mark L. Hudak, Roberta A. Ballard, Dennis E. Mayock, Philip L. Ballard, Sandra R. Wadlinger, Eric C. Eichenwald, Asha R. Puri, Jeffrey D. Merrill, Sergio G. Golombek, Stephen E. Welty, Michele C. Walsh, Anna Maria Hibbs, Roderic H. Phibbs, Donald R. Null, William E Truog, Jeanette M. Asselin, Christine E. Coburn, Sherry E. Courtney, and Xianqun Luan
- Subjects
Lung Diseases ,Male ,medicine.medical_treatment ,Birth weight ,Gestational Age ,Infant, Premature, Diseases ,Nitric Oxide ,Placebo ,Drug Administration Schedule ,Nitric oxide ,chemistry.chemical_compound ,Double-Blind Method ,Administration, Inhalation ,medicine ,Humans ,Infant, Very Low Birth Weight ,Bronchopulmonary Dysplasia ,Mechanical ventilation ,Lung ,business.industry ,Age Factors ,Infant, Newborn ,Postmenstrual Age ,Gestational age ,General Medicine ,Length of Stay ,medicine.disease ,Respiration, Artificial ,Survival Analysis ,medicine.anatomical_structure ,Bronchopulmonary dysplasia ,chemistry ,Anesthesia ,Female ,business ,Infant, Premature - Abstract
Bronchopulmonary dysplasia in premature infants is associated with prolonged hospitalization, as well as abnormal pulmonary and neurodevelopmental outcome. In animal models, inhaled nitric oxide improves both gas exchange and lung structural development, but the use of this therapy in infants at risk for bronchopulmonary dysplasia is controversial.We conducted a randomized, stratified, double-blind, placebo-controlled trial of inhaled nitric oxide at 21 centers involving infants with a birth weight of 1250 g or less who required ventilatory support between 7 and 21 days of age. Treated infants received decreasing concentrations of nitric oxide, beginning at 20 ppm, for a minimum of 24 days. The primary outcome was survival without bronchopulmonary dysplasia at 36 weeks of postmenstrual age.Among 294 infants receiving nitric oxide and 288 receiving placebo birth weight (766 g and 759 g, respectively), gestational age (26 weeks in both groups), and other characteristics were similar. The rate of survival without bronchopulmonary dysplasia at 36 weeks of postmenstrual age was 43.9 percent in the group receiving nitric oxide and 36.8 percent in the placebo group (P=0.042). The infants who received inhaled nitric oxide were discharged sooner (P=0.04) and received supplemental oxygen therapy for a shorter time (P=0.006). There were no short-term safety concerns.Inhaled nitric oxide therapy improves the pulmonary outcome for premature infants who are at risk for bronchopulmonary dysplasia when it is started between 7 and 21 days of age and has no apparent short-term adverse effects. (ClinicalTrials.gov number, NCT00000548 [ClinicalTrials.gov] .).
- Published
- 2006
6. Inhaled Nitric Oxide for Preterm Infants — Who Benefits?
- Author
-
Michele C. Walsh and Richard J. Martin
- Subjects
medicine.medical_specialty ,business.industry ,General Medicine ,Bioinformatics ,Nitric oxide ,Critical phase ,chemistry.chemical_compound ,Respiratory failure ,chemistry ,Medicine ,Respiratory system ,business ,Intensive care medicine ,Organ system - Abstract
Endogenously released nitric oxide is widely recognized to play a key role in multiple vertebrate organ systems, and its deficiency disrupts pulmonary parenchymal and vascular development. These observations have suggested that exogenously inhaled nitric oxide might protect the respiratory and the central nervous systems during a critical phase of development and thus improve outcomes in preterm infants. In this issue of the Journal, Mestan et al.1 and Van Meurs et al.2 assess the utility of inhaled nitric oxide in preterm neonates with respiratory failure, with contrasting results. Mestan and colleagues report improved cognitive neurodevelopmental outcome in two-year-olds who had been . . .
- Published
- 2005
7. Bronchopulmonary Dysplasia — No Simple Solution
- Author
-
Michele C. Walsh-Sukys and Richard J. Martin
- Subjects
Pediatrics ,medicine.medical_specialty ,Bronchopulmonary dysplasia ,Respiratory distress ,business.industry ,medicine ,General Medicine ,medicine.disease ,business ,Glucocorticoid ,Simple (philosophy) ,medicine.drug - Abstract
Progress in the treatment of neonates with the respiratory distress syndrome has been one of the medical success stories of the past 15 years. During this time, the widespread use of glucocorticoid...
- Published
- 1999
8. Oxygen-Saturation Targets in Extremely Preterm Infants
- Author
-
Michele C. Walsh, Edward F. Bell, and Waldemar A. Carlo
- Subjects
Risk ,Pediatrics ,medicine.medical_specialty ,Informed Consent ,business.industry ,Extremely preterm ,Infant, Newborn ,Oxygen Inhalation Therapy ,General Medicine ,Oxygen ,Survival Rate ,Very preterm ,Infant, Extremely Premature ,medicine ,Humans ,Multicenter Studies as Topic ,Retinopathy of Prematurity ,business ,Randomized Controlled Trials as Topic ,Oxygen saturation (medicine) - Abstract
In this letter, authors of the SUPPORT study, which compared lower oxygen-saturation target levels with higher levels in very preterm infants, respond to criticisms of the trial.
- Published
- 2013
9. Target Ranges of Oxygen Saturation in Extremely Preterm Infants
- Author
-
Roger G. Faix, Bradley A. Yoder, Michele C. Walsh, T. Michael O'Shea, Vivek Narendran, Namasivayam Ambalavanan, Waldemar A. Carlo, Nancy S. Newman, Abhik Das, W. Kenneth Poole, Richard A. Ehrenkranz, Anthony J. Piazza, Rosemary D. Higgins, Marie G. Gantz, Beena G. Sood, Krisa P. Van Meurs, Edward F. Bell, Brenda H. Morris, Abbot R. Laptook, Shahnaz Duara, Neil N. Finer, Wade Rich, Kurt Schibler, Dale L. Phelps, Ivan D. Frantz, Pablo J. Sánchez, Brenda B. Poindexter, Nirupama Laroia, Kristi L. Watterberg, and C. Michael Cotten
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,medicine.medical_treatment ,Positive pressure ,Kaplan-Meier Estimate ,Article ,law.invention ,Randomized controlled trial ,Reference Values ,law ,Infant Mortality ,Intubation, Intratracheal ,Humans ,Medicine ,Retinopathy of Prematurity ,Continuous positive airway pressure ,Hospital Mortality ,Oximetry ,Proportional Hazards Models ,Randomized Controlled Trials as Topic ,Oxygen saturation (medicine) ,Continuous Positive Airway Pressure ,medicine.diagnostic_test ,business.industry ,Extremely preterm ,Incidence (epidemiology) ,Infant, Newborn ,Oxygen Inhalation Therapy ,Retinopathy of prematurity ,Pulmonary Surfactants ,General Medicine ,Oxygenation ,medicine.disease ,Confidence interval ,Infant mortality ,Oxygen ,Pulse oximetry ,Anesthesia ,Relative risk ,Female ,business ,Infant, Premature ,Retinopathy - Abstract
BACKGROUND Previous studies have suggested that the incidence of retinopathy is lower in preterm infants with exposure to reduced levels of oxygenation than in those exposed to higher levels of oxygenation. However, it is unclear what range of oxygen saturation is appropriate to minimize retinopathy without increasing adverse outcomes. METHODS We performed a randomized trial with a 2-by-2 factorial design to compare target ranges of oxygen saturation of 85 to 89% or 91 to 95% among 1316 infants who were born between 24 weeks 0 days and 27 weeks 6 days of gestation. The primary outcome was a composite of severe retinopathy of prematurity (defined as the presence of threshold retinopathy, the need for surgical ophthalmologic intervention, or the use of bevacizumab), death before discharge from the hospital, or both. All infants were also randomly assigned to continuous positive airway pressure or intubation and surfactant. RESULTS The rates of severe retinopathy or death did not differ significantly between the lower-oxygen-saturation group and the higher-oxygen-saturation group (28.3% and 32.1%, respectively; relative risk with lower oxygen saturation, 0.90; 95% confidence interval [CI], 0.76 to 1.06; P=0.21). Death before discharge occurred more frequently in the lower-oxygen-saturation group (in 19.9% of infants vs. 16.2%; relative risk, 1.27; 95% CI, 1.01 to 1.60; P=0.04), whereas severe retinopathy among survivors occurred less often in this group (8.6% vs. 17.9%; relative risk, 0.52; 95% CI, 0.37 to 0.73; P
- Published
- 2010
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.